Step Pharma
Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1).
1
Funding Rounds
$41.0m
Money raised
Overview
Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1).
- Website:
- Business model: B2B
- Headquarters: Paris
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Step Pharma has raised a total of $41m in funding over 1 rounds.
Key Insights:
- Step Pharma March 2021 Series B Funding Round: $41m
Step Pharma March 2021 Series B Funding Round
$41m
Industries
Step Pharma is active in the following industries: